Abstract
The term "adherence" is used to describe whether drugs are taken as prescribed. This article outlines what is known about adherence for several central drug classes, which factors modify adherence, the consequences of low adherence and how adherence can be improved. We reviewed a selection of studies of adherence for the following seven drug classes: antidiabetics, antiepileptics, antihypertensives, statins, psychotropic drugs, antibiotics and analgesics. For antidiabetics, the proportion of patients with high adherence varied between 31 % and 80 % in the different studies. The corresponding figures for the other drug classes were: antiepileptics, 61-74 %; antihypertensives, 23-73 %; statins, 25-44 %; psychotropic drugs, 21-80 %; antibiotics, 41-70 % and analgesics, 41-53 %. As a general rule, adherence declined with time. For serious diseases, a decline in adherence led to a worsening of symptoms and an increased risk of hospitalisation and death. Dosing once daily proved to result in higher adherence than multiple daily dosing. Complex therapy regimes, depression, impaired cognitive function, side effects and inadequate follow-up reduce adherence. It is important to achieve high adherence, not least for serious diseases. In o...Continue Reading
References
Dec 1, 1996·American Journal of Public Health·M MonaneJ Avorn
Apr 1, 1997·Seizure : the Journal of the British Epilepsy Association·D BuckD W Chadwick
May 9, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·J A Cramer, R Rosenheck
Dec 23, 1999·The Pediatric Infectious Disease Journal·J E HoppeH K Selbmann
May 29, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·B L SvarstadJ K Sweeney
Dec 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C MiaskowskiK Schumacher
Feb 16, 2002·Journal of Clinical Pharmacy and Therapeutics·X S RenD R Miller
Apr 12, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·P T DonnanA D Morris
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·Przemyslaw Kardas
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Joshua S BennerJerry Avorn
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu
Dec 25, 2003·Clinical Therapeutics·Rajesh BalkrishnanRoger T Anderson
Apr 28, 2004·Diabetes Care·Joyce A Cramer
Jun 24, 2004·Journal of General Internal Medicine·Jeffrey J EllisA Mark Fendrick
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Sep 13, 2005·Clinical Therapeutics·Robin P HertzMichael B Lustik
May 3, 2006·The Journal of Clinical Psychiatry·Haya Ascher-SvanumJeff W Swanson
Jun 23, 2006·BMJ : British Medical Journal·Scot H SimpsonJeffrey A Johnson
Sep 27, 2006·Archives of Internal Medicine·P Michael HoDavid J Magid
May 15, 2007·Medical Care·Ayse AkincigilStephen Crystal
Aug 7, 2007·The American Journal of Medicine·Sripal BangaloreFranz H Messerli
Aug 21, 2007·Journal of Pain and Symptom Management·Wendy H OldenmengerCarin C D van der Rijt
Nov 23, 2007·Epilepsia·Keith L DavisHeather M Edin
Dec 20, 2007·International Clinical Psychopharmacology·Koen DemyttenaereSangeleer Michèle
Jun 21, 2008·Neurology·E FaughtM C Cunnington
Aug 22, 2008·The Clinical Journal of Pain·Berit Taraldsen ValebergTone Rustøen
Nov 19, 2008·The Journal of Antimicrobial Chemotherapy·Carl LlorMarc Miravitlles
Citations
Sep 5, 2014·International Journal of Clinical Pharmacy·Helle HåkonsenElse-Lydia Toverud
Feb 21, 2013·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Roar Dyrkorn, Pål-Didrik Hoff Roland
Oct 13, 2016·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Frode EdvardsenArne Helland
Oct 13, 2016·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Halvor LundgaardOlav Spigset
Oct 19, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Lars Slørdal